Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock

Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock



Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.


www.bloomberg.com
#Bayer #Stroke #Drug #Meets #Trial #Goal #Hitting #Roadblock

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *